Marvell Technology Shares Climb on AI Chip Demand Optimism Brent Oil Surges 4 as US Strikes on Iran Drive Energy Prices Higher US Stocks Rebound Maxvolt Energy Targets South India Expansion With 73 Million Renewable Energy and Lithium Recycling Plan US Jobless Claims Remain at Historically Low Levels Signaling Labor Market Strength AI in Filmmaking Cannes Summit Highlights Industry Divisions Over Generative Technology IntermediateTerm Technical Outlook Turns Bullish What Investors Should Know WEN Q1 2026 Earnings EPS Surges Past Estimates as Wendys Maintains Profit Discipline HBANL Q1 2026 Earnings Preferred Series Reports Underlying Common EPS Miss with Flat Stock Reaction SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves LGI Homes Q1 2026 Earnings Stellar EPS Beat Drives DoubleDigit Surprise Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground WPP Q4 2025 Earnings EPS Beats Estimates Amid Cautious Investor Sentiment BrightSpire Capital BRSP Edges Higher as Shares Hold Above Key Support HCMAU Units Remain Stable at 1037 as Market Digests PreMerger Phase HCM III Acquisition Corp WF Holding Limited WFF Regains Ground as Shares Rise Nearly 3 Cantor Equity Partners II Inc CEPT Slips 122 Support Test Looms Amid Low Volume SBA Communications SBAC Slips Tower REIT Tests Key Support After 187 Decline Lucid Diagnostics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Firm Advances Commercial Rollout Home Federal Bancorp Inc of Louisiana HFBL Q3 2025 Earnings Profitability Holds Steady Amid Quiet Market Response DTG Q1 2026 Earnings EPS Miss Raises Caution on Utility Performance KLIC Q1 2026 Earnings EPS Surges Past Estimates as Semiconductor Capital Equipment Demand Strengthens MED Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction VALE Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Dow Jones Hits Record Close as AI Rally Pauses SP 500 and Nasdaq Stay Muted Utz Brands Inc UTZ Q1 2026 Earnings EPS Beats Expectations Stock Climbs on Profitability Strength Fate Therapeutics Rallies 95 as FATE Stock Breaks Above Key Support Level